The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,807

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

March 24, 2023

Study Completion Date

March 24, 2023

Conditions
COVID-19
Interventions
DRUG

Pyramax

Pyronaridine-Artesunate(180/60mg) tablet for 3days.

DRUG

Placebo

Placebo tablet for 3days.

Trial Locations (66)

Unknown

Instituto Medico Platense, Buenos Aires

Ciprec - Centro de Investigación Y Prevención Cardiovascular, Caba

"Hospital de Agudos Dr. Ignacio Pirovano", Caba

Instituto Médico Río Cuarto, Córdoba

Clinica Privada Independencia, Munro

Centro Médico IPAM, Santa Fe

Clínica Universidad de los Andes, Las Condes

Hospital Regional Dr. Leonardo Guzman de Antofagasta, Antofagasta

Centro de Estudios Clínicos e Investigaciones Médicas - CECIM, Santiago

IntegraMédica Las Condes, Santiago

Clínica de la Costa Ltda, Barranquilla

Corazon IPS S.A.S, Barranquilla

IPS Centro Cientifico Asisitencial S.A.S, Barranquilla

Centro de Investigacion en Reumatología y Especialidades Médicas-CIREEM S.A.S, Bogotá

Clinica Universidad de la Sabana, Chía

Fundación Cardiovascular de Colombia, Floridablanca

Asociación IPS Médicos Internistas de Caldas S.A.S, Manizales

Healthy Medical Center S.A.S., Manizales

Programa de Estudio y Control de Enfermedades Tropicales PECET. Universidad de Antoquia, Medellín

Clinisalud del Sur S.A.S, Sabaneta

Fundación Valle del Lili, Santiago de Cali

Institución Prestadora de servicios de salud Centro Medico Julian Coronel S.A.S, Santiago de Cali

Krakowskie Centrum Medyczne, Krakow

Centrum Medyczne AMED Oddział w Łodzi, Lodz

NZOZ Le Med, Lodz

MEDICOME - Oświęcimskie Centrum Medyczne, Oświęcim

Przychodnia Lekarska Eskulap, Skierniewice

FutureMeds Warszawa Centrum, Warsaw

CMS Sp. z o.o., Wysokie Mazowieckie

The Catholic University of Korea, Bucheon ST. Mary's Hospital, Bucheon-si

Busan Medical Center, Busan

Keimyung University Dongsan Medical Center, Daegu

KyungPook National University Chilgok Hospital, Daegu

Kyungpook National University Hospital, Daegu

Chungnam national University Hospital, Daejeon

Chungnam National University Sejong Hospital, Daejeon

Gimpo Woori Hospital, Gimpo-si

Myongji Hospital, Goyang-si

Chonnam National University Bitgoeul Hospital, Gwangju

Gyeonggi Medical Center An-sung Hospital, Gyeonggi-do

Gyeonggi Medical Center Icheon Hospital, Gyeonggi-do

Gyeonggi Medical Center Paju Hospital, Gyeonggi-do

Gyeonggi Medical Center Pocheon Hospital, Gyeonggi-do

Gyeonggi Medical Center Suwon Hospital, Gyeonggi-do

Gyeonggi Medical Center Uijeongbu Hospital, Gyeonggi-do

Inje University Ilsan Paik Hospital, Ilsan

Incheon Sejong Hospital, Incheon

Inha University Hospital, Incheon

Jeonbuk National University Hospital, Jeonju

Pusan National University Hospital, Pusan

Boramae Medical Center, Seoul

Chosun University Hospital, Seoul

Chung-Ang University Hospital, Seoul

Eunpyeong St. Marys' Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyung Hee University Medical Center, Seoul

National Medical Center, Seoul

Sahmyook medical Center, Seoul

Seoul Medical Center, Seoul

Seoul Red Cross Hospital, Seoul

Ajou University Hospital, Suwon

Yongin Severance Hospital, Yŏngin

Bridle Road Clinic (Liverpool), Birkenhead

Soho Road Health Centre, Birmingham

piso 4

Icegclinic, La Florida

carrera 7

Centro de Estudios e Investigación en salud-CEIS, Bogotá

All Listed Sponsors
lead

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY

NCT05084911 - The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3) | Biotech Hunter | Biotech Hunter